Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge represented iZettle AB in connection with fundraising
Mandate

Vinge represented iZettle AB in connection with fundraising

October 31, 2011

iZettle AB has made an directed issuance of new shares and issuance of warrants of EUR 8.2 million to venture capital firms Index Ventures and Creandum and Charles Dunstone, managing director and co-founder of The Carphone Warehouse, to be able to develop its payment service and expand outside of Sweden.

iZettle AB enables business entrepreneurs and private persons to make transactions with credit cards by downloading iZettle AB:s app to iPhone or iPad (with or without chip-card reader).

Vinga represented iZettle AB and the team consisted of partner Henrik Wenckert and associates Josefin Nowén, Maria Eierborg and Katarina Rykowska.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026